Register entry

Ardena US, LLC

Data as of · How to read this entry

Registered sites
0
Active NDC listings
8
Live patents
0
Countries
0
Catalogue

Drug listings by form and route

8

8 active NDC listings: 8 drug for further processing. By marketing category: DRUG FOR FURTHER PROCESSING 5, EXPORT ONLY 3.

Dosage formNDCs
capsule4
tablet3
powder1
RouteNDCs
Labeller name on the listingNDCs
ardena us, llc8
Catalogue

Marketed products

8
BrandGeneric nameForm / routeNDC
-Atazanavirpowder85247-0001DRUG FOR FURTHER PROCESSING
-ENCORAFENIBcapsule85247-0004EXPORT ONLY
-ENCORAFENIBcapsule85247-0005EXPORT ONLY
-Encorafenibcapsule85247-0002DRUG FOR FURTHER PROCESSING
-Encorafenibcapsule85247-0003DRUG FOR FURTHER PROCESSING
-Nilotinibtablet85247-0007DRUG FOR FURTHER PROCESSING
-Nilotinibtablet85247-0008DRUG FOR FURTHER PROCESSING
-POSACONAZOLEtablet85247-0006EXPORT ONLY
Compare

Other companies listing encorafenib

Enquiry

Common questions

Is Ardena US, LLC FDA approved?
Ardena US, LLC holds no registered establishment of its own; 8 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does Ardena US, LLC make?
8 products are listed under Ardena US, LLC in the openFDA NDC Directory, most often as capsule; tablet; powder. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.